<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sathasivam HP</submitter><funding>Ministry of Health Malaysia.</funding><funding>Medical Research Council</funding><pagination>413-421</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8329212</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>125(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>This study was undertaken to develop and validate a gene expression signature that characterises oral potentially malignant disorders (OPMD) with a high risk of undergoing malignant transformation.&lt;h4>Methods&lt;/h4>Patients with oral epithelial dysplasia at one hospital were selected as the 'training set' (n = 56) whilst those at another hospital were selected for the 'test set' (n = 66). RNA was extracted from formalin-fixed paraffin-embedded (FFPE) diagnostic biopsies and analysed using the NanoString nCounter platform. A targeted panel of 42 genes selected on their association with oral carcinogenesis was used to develop a prognostic gene signature. Following data normalisation, uni- and multivariable analysis, as well as prognostic modelling, were employed to develop a</pubmed_abstract><journal>British journal of cancer</journal><pubmed_title>Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology.</pubmed_title><pmcid>PMC8329212</pmcid><funding_grant_id>MR/N005872/1</funding_grant_id><pubmed_authors>Sathasivam HP</pubmed_authors><pubmed_authors>Nugent M</pubmed_authors><pubmed_authors>Robinson M</pubmed_authors><pubmed_authors>Kist R</pubmed_authors><pubmed_authors>Sloan P</pubmed_authors><pubmed_authors>Haider S</pubmed_authors><pubmed_authors>Thomson P</pubmed_authors><pubmed_authors>Alexander J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology.</name><description>&lt;h4>Background&lt;/h4>This study was undertaken to develop and validate a gene expression signature that characterises oral potentially malignant disorders (OPMD) with a high risk of undergoing malignant transformation.&lt;h4>Methods&lt;/h4>Patients with oral epithelial dysplasia at one hospital were selected as the 'training set' (n = 56) whilst those at another hospital were selected for the 'test set' (n = 66). RNA was extracted from formalin-fixed paraffin-embedded (FFPE) diagnostic biopsies and analysed using the NanoString nCounter platform. A targeted panel of 42 genes selected on their association with oral carcinogenesis was used to develop a prognostic gene signature. Following data normalisation, uni- and multivariable analysis, as well as prognostic modelling, were employed to develop a</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2026-05-31T23:57:31.989Z</modification><creation>2024-10-17T20:01:23.186Z</creation></dates><accession>S-EPMC8329212</accession><cross_references><pubmed>33972745</pubmed><doi>10.1038/s41416-021-01411-z</doi></cross_references></HashMap>